DEFERRED Expense EXCHANGE AGREEMENTDeferred Expense Exchange Agreement • December 19th, 2019 • Nanoviricides, Inc. • Services-commercial physical & biological research
Contract Type FiledDecember 19th, 2019 Company IndustryThis DEFERRED EXPENSE EXCHANGE AGREEMENT (this “Agreement”), is entered into as of December 17, 2019 (“Execution Date”), by and between NanoViricides, Inc., a Nevada corporation (the “Company”) and TheraCour Pharma, Inc., a Connecticut corporation (“TheraCour”) (collectively, the “Parties”).
DEFERRED EXPENSE EXCHANGE AGREEMENTDeferred Expense Exchange Agreement • September 1st, 2023 • Nanoviricides, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 1st, 2023 Company IndustryThis DEFERRED EXPENSE EXCHANGE AGREEMENT (this “Exchange Agreement”), effective of July 19, 2023 (“Execution Date”), by and between NanoViricides, Inc., a Nevada corporation (the “Company”) and TheraCour Pharma, Inc., a Connecticut corporation (“TheraCour”) (collectively, the “Parties”).